Erjiao Xu
- Hepatology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Surgery
- Epidemiology
- Pulmonary and Respiratory Medicine
- Co-authors
- Kai LiRongqin ZhengQingjing ZengZhongzhen SuJie RenRen MaoJun ZhouFei Yan
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (32 papers)Liver Disease Diagnosis and Treatment (15 papers)MRI in cancer diagnosis (14 papers)
In The Last Decade
Erjiao Xu
43 papers receiving 582 citations
Peers
Comparison fields: 5 of 58
- Hepatology 339
- Radiology, Nuclear Medicine and Imaging 219
- Surgery 193
- Epidemiology 166
- Pulmonary and Respiratory Medicine 141
Countries citing papers authored by Erjiao Xu
This map shows the geographic impact of Erjiao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erjiao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erjiao Xu more than expected).
Fields of papers citing papers by Erjiao Xu
This network shows the impact of papers produced by Erjiao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erjiao Xu. The network helps show where Erjiao Xu may publish in the future.
Co-authorship network of co-authors of Erjiao Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Erjiao Xu. A scholar is included among the top collaborators of Erjiao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erjiao Xu. Erjiao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 59 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 43 | |
| 12 | 43 | |
| 13 | 0 | |
| 14 | 1 | |
| 15 | 0 | |
| 16 | 1 | |
| 17 | 29 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 10 |
About Erjiao Xu
Erjiao Xu is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 48 papers that have together received 589 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Liver Disease Diagnosis and Treatment (15 papers) and MRI in cancer diagnosis (14 papers). The work is most often cited by research in Hepatology (339 citations), Radiology, Nuclear Medicine and Imaging (219 citations) and Health Informatics (12 citations). Erjiao Xu has collaborated with scholars based in China and France. Frequent co-authors include Kai Li, Rongqin Zheng, Qingjing Zeng, Zhongzhen Su, Rongqin Zheng, Jie Ren, Ren Mao, Jun Zhou, Fei Yan and Huanyi Guo. Their work appears in journals such as Physics in Medicine and Biology, Ultrasonics Sonochemistry and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.